Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CSF3R |
| Variant | T618I |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | CSF3R T618I lies within the extracellular domain proximal to the transmembrane domain of the Csf3r protein (PMID: 23656643). T618I confers a gain of function to the Csf3r protein as demonstrated by increased proliferation (PMID: 23656643), increased colony formation (PMID: 31784538), increased downstream Jak-Stat signaling in transformed cells in culture (PMID: 23656643), and led to the development of leukemia in a mouse model (PMID: 31784538). |
| Associated Drug Resistance | |
| Category Variants Paths |
CSF3R mutant CSF3R act mut CSF3R T618I |
| Transcript | NM_000760.4 |
| gDNA | chr1:g.36467833G>A |
| cDNA | c.1853C>T |
| Protein | p.T618I |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_172313.2 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_005270493 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| NM_000760 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_011540749.1 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_047446753.1 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_011540749.1 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_011540748 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| NM_000760.3 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| NM_172313.3 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| NM_172313 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_011540748.3 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_011540749 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_005270493.1 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| NM_000760.4 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| NM_156039.3 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| NM_156039 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_017000370 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| NM_156039.3 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_017000370.1 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| XM_005270493.1 | chr1:g.36467833G>A | c.1853C>T | p.T618I | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|